BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 14504110)

  • 41. Clinical relevance of CD10 expression in childhood ALL. The Italian Association for Pediatric Hematology and Oncology (AIEOP).
    Consolini R; Legitimo A; Rondelli R; Guguelmi C; Barisone E; Lippi A; Cantù-Rajnoldi A; Aricò M; Conter V; Cocito MG; Putti MC; Pession A; Masera G; Biondi A; Basso G
    Haematologica; 1998 Nov; 83(11):967-73. PubMed ID: 9864914
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Site-specific deletions involving the tal-1 and sil genes are restricted to cells of the T cell receptor alpha/beta lineage: T cell receptor delta gene deletion mechanism affects multiple genes.
    Breit TM; Mol EJ; Wolvers-Tettero IL; Ludwig WD; van Wering ER; van Dongen JJ
    J Exp Med; 1993 Apr; 177(4):965-77. PubMed ID: 8459224
    [TBL] [Abstract][Full Text] [Related]  

  • 43. TEL gene rearrangement in acute lymphoblastic leukemia: a new genetic marker with prognostic significance.
    Rubnitz JE; Downing JR; Pui CH; Shurtleff SA; Raimondi SC; Evans WE; Head DR; Crist WM; Rivera GK; Hancock ML; Boyett JM; Buijs A; Grosveld G; Behm FG
    J Clin Oncol; 1997 Mar; 15(3):1150-7. PubMed ID: 9060558
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prognostically significant fusion oncogenes in Pakistani patients with adult acute lymphoblastic leukemia and their association with disease biology and outcome.
    Sabir N; Iqbal Z; Aleem A; Awan T; Naeem T; Asad S; Tahir AH; Absar M; Hasanato RM; Basit S; Chishti MA; Faiyaz Ul-Haque M; Khalid AM; Sabar MF; Rasool M; Karim S; Khan M; Samreen B; Akram AM; Siddiqi MH; Shahzadi S; Shahbaz S; Ali AS; Mahmood A; Akram M; Saeed T; Saleem A; Mohsin D; Shah IH; Khalid M; Asif M; Iqbal M; Akhtar T
    Asian Pac J Cancer Prev; 2012; 13(7):3349-55. PubMed ID: 22994759
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic role of minimal residual disease in mature B-cell acute lymphoblastic leukemia of childhood.
    Mussolin L; Pillon M; Conter V; Piglione M; Lo Nigro L; Pierani P; Micalizzi C; Buffardi S; Basso G; Zanesco L; Rosolen A
    J Clin Oncol; 2007 Nov; 25(33):5254-61. PubMed ID: 18024872
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characterization of ABL1 expression in adult T-cell acute lymphoblastic leukemia by oligonucleotide array analysis.
    Chiaretti S; Tavolaro S; Ghia EM; Ariola C; Matteucci C; Elia L; Maggio R; Messina M; Ricciardi MR; Vitale A; Ritz J; Mecucci C; Guarini A; Foà R
    Haematologica; 2007 May; 92(5):619-26. PubMed ID: 17488685
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical and biological relevance of genetic alterations in pediatric T-cell acute lymphoblastic leukemia in Taiwan.
    Yeh TC; Liang DC; Liu HC; Jaing TH; Chen SH; Hou JY; Yang CP; Huang YJ; Yao HW; Huang TY; Lin TH; Shih LY
    Pediatr Blood Cancer; 2019 Jan; 66(1):e27496. PubMed ID: 30280491
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic importance of TLX1 (HOX11) oncogene expression in adults with T-cell acute lymphoblastic leukaemia.
    Ferrando AA; Neuberg DS; Dodge RK; Paietta E; Larson RA; Wiernik PH; Rowe JM; Caligiuri MA; Bloomfield CD; Look AT
    Lancet; 2004 Feb; 363(9408):535-6. PubMed ID: 14975618
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Evaluation of the efficacy of two successive protocols on pediatric acute lymphoblastic leukemia with E2A-PBX1 fusion gene].
    Mei YY; Gao C; Cui L; Zhao XX; Zhao W; Li WJ; Wang KL; Jiang J; Zhang RD; Xie J; Shi HW; Wang B; Zhang YH; Ma XL; Zhou X; Wu MY; Li ZG
    Zhonghua Er Ke Za Zhi; 2013 Jun; 51(6):467-71. PubMed ID: 24120066
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [HOX11L2 expression and its clinical significance in paraffin-embedded T-lymphoblastic lymphoma].
    Pan Y; Li GD; Liu WP; Zhou Q; Zhang WY
    Zhonghua Xue Ye Xue Za Zhi; 2005 Oct; 26(10):585-8. PubMed ID: 16532965
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of TCR status and genotype on outcome in adult T-cell acute lymphoblastic leukemia: a LALA-94 study.
    Asnafi V; Buzyn A; Thomas X; Huguet F; Vey N; Boiron JM; Reman O; Cayuela JM; Lheritier V; Vernant JP; Fiere D; Macintyre E; Dombret H
    Blood; 2005 Apr; 105(8):3072-8. PubMed ID: 15637138
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Persistence of E2A/PBX1 transcripts in t(1;19) childhood acute lymphoblastic leukemia: correlation with chemotherapy intensity and clinical outcome.
    Lanza C; Gottardi E; Gaidano G; Vivenza C; Parziale A; Perfetto F; Fornaci M; Barisone E; Madon E; Basso G; Saglio G
    Leuk Res; 1996 May; 20(5):441-3. PubMed ID: 8683984
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Occurrence of TEL-AML1 fusion resulting from (12;21) translocation in human early B-lineage leukemia cell lines.
    Uphoff CC; MacLeod RA; Denkmann SA; Golub TR; Borkhardt A; Janssen JW; Drexler HG
    Leukemia; 1997 Mar; 11(3):441-7. PubMed ID: 9067587
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Specific alternative HOX11 transcripts are expressed in paediatric neural tumours and T-cell acute lymphoblastic leukaemia.
    Watt PM; Hoffmann K; Greene WK; Brake RL; Ford J; Kees UR
    Gene; 2003 Dec; 323():89-99. PubMed ID: 14659882
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Slower molecular response to treatment predicts poor outcome in patients with TEL/AML1 positive acute lymphoblastic leukemia: prospective real-time quantitative reverse transcriptase-polymerase chain reaction study.
    Madzo J; Zuna J; Muzíková K; Kalinová M; Krejcí O; Hrusák O; Otová B; Starý J; Trka J
    Cancer; 2003 Jan; 97(1):105-13. PubMed ID: 12491511
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Spectral karyotyping and interphase FISH reveal abnormalities not detected by conventional G-banding. Implications for treatment stratification of childhood acute lymphoblastic leukaemia: detailed analysis of 70 cases.
    Nordgren A; Heyman M; Sahlén S; Schoumans J; Söderhäll S; Nordenskjöld M; Blennow E
    Eur J Haematol; 2002 Jan; 68(1):31-41. PubMed ID: 11952819
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Clinical Characteristics and Treatment Efficacy of Children with SIL/TAL1 Positive T-Cell Acute Lymphoblastic Leukemia].
    Liu X; Li WJ; Zhao XX; Gao C; Zhao W; Jiang J; Zhang RD; Xie J; Shi HW; Wang B; Zhang YH; Ma XL; Zhou X; Wu MY; Cui L; Li ZG
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Jun; 24(3):681-6. PubMed ID: 27342490
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Incidence and clinical outcome of children with BCR/ABL-positive acute lymphoblastic leukemia (ALL). A prospective RT-PCR study based on 673 patients enrolled in the German pediatric multicenter therapy trials ALL-BFM-90 and CoALL-05-92.
    Schlieben S; Borkhardt A; Reinisch I; Ritterbach J; Janssen JW; Ratei R; Schrappe M; Repp R; Zimmermann M; Kabisch H; Janka-Schaub G; Bartram CR; Ludwig WD; Riehm H; Lampert F; Harbott J
    Leukemia; 1996 Jun; 10(6):957-63. PubMed ID: 8667652
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Promoter demethylation accompanies reactivation of the HOX11 proto-oncogene in leukemia.
    Watt PM; Kumar R; Kees UR
    Genes Chromosomes Cancer; 2000 Dec; 29(4):371-7. PubMed ID: 11066085
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular and cytogenetic characterization of a new case of t(5;17)(q35;q21) variant acute promyelocytic leukemia.
    Nicci C; Ottaviani E; Luatti S; Grafone T; Tonelli M; Motta MR; Malagola M; Marzocchi G; Martinelli G; Baccarani M; Testoni N
    Leukemia; 2005 Mar; 19(3):470-2. PubMed ID: 15674421
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.